"Lack of Cleaning" in Brain Cells is Central to Alzheimer’s Disease
News Feb 19, 2019 | Original Press Release from the University of Copenhagen
Credit: Nevit Dilmen, NIH 3D Print Exchange, National Institutes of Health via Flickr under CC BY-NC 2.0 https://creativecommons.org/licenses/by-nc/2.0/
Scientists around the world are still struggling to understand Alzheimer's better in order to be able to treat and potentially prevent the development of the debilitating disease in the future. No new medications have been approved during recent years.
In a new study in the scientific journal Nature Neuroscience, an international team of researchers from the University of Copenhagen, National Institutes of Health and the University of Oslo among others have come closer to a new way of attacking the disease. They target the efforts towards the cleaning process in the brain cells called mitophagy.
‘When the cleaning system does not work properly, there will be an accumulation of defective mitochondria in the brain cells. And this may be really dangerous. At any rate, the poor cleaning system is markedly present in cells from both humans and animals with Alzheimer's. And when we improve the cleaning in live animals, their Alzheimer's symptoms almost disappear,’ says Vilhelm Bohr, author of the study and affiliate professor at the Center for Healthy Aging and National Institutes of Health.
Defect Energy Factories
The researchers have looked more closely at the cleaning process in brain cells from deceased Alzheimer's patients, in Alzheimer's-induced stem cells and in live mice and roundworms with Alzheimer's. In addition, they have also tested active substances targeted at the cleaning process in the animal models.
‘It significantly strengthens our results that the cleaning process seems to be important in both human cells and across different animal species. And then it is encouraging that in living animals we are able to improve the central Alzheimer's symptoms, memory and learning,’ says Vilhelm Bohr.
The mitochondria lie inside the cell and can be seen as the cell's energy factories. Mitophagy breaks down defective mitochondria and reuses the proteins that they consist of. It is known from previous research that dysfunctional mitophagy is associated with poor function and survival of nerve cells, but so far, the connection with Alzheimer's is unclear.
Slowing Down the Accumulation
In both Alzheimer's and other states of dementia, there is an accumulation of the proteins tau and beta amyloid in the brain, leading to cell death. In the new animal models, the researchers show that when boosting the mitophagy, such accumulation will slow down.
The researchers believe that altogether their findings indicate that the cleaning process is a potential target for the treatment of Alzheimer's, which should be further investigated. They therefore plan to start clinical trials in humans in the near future.
This article has been republished from materials provided by the University of Copenhagen. Note: material may have been edited for length and content. For further information, please contact the cited source.
Reference: Fang, E. F., Hou, Y., Palikaras, K., Adriaanse, B. A., Kerr, J. S., Yang, B., … Bohr, V. A. (2019). Mitophagy inhibits amyloid-β and tau pathology and reverses cognitive deficits in models of Alzheimer’s disease. Nature Neuroscience, 1. https://doi.org/10.1038/s41593-018-0332-9
Adult depression has long been associated with shrinkage of the hippocampus, a brain region that plays an important role in memory and response to stress. Now, new research has linked participation in team sports to larger hippocampal volumes in children and less depression in boys ages 9 to 11.
Researchers have discovered a brain process common to sleep and ageing in research that could pave the way for new treatments for insomnia. The scientists report how oxidative stress leads to sleep. Oxidative stress is also believed to be a reason why we age and a cause of degenerative diseases.READ MORE
Patients in a new Northwestern Medicine study were able to comprehend words that were written but not said aloud. They could write the names of things they saw but not verbalize them. This provides an insight into the brain degeneration that defines the rare dementia termed primary progressive aphasia.